Komori
Share Issuance and Disposal4586Medrx Co.,Ltd.Pharmaceuticals

Notice Regarding the Large-Scale Exercise of the 35th Stock Acquisition Rights (with Exercise Price Adjustment Clause) Issued Through a Third-Party Allotment

A total of 23,343 of the 35th Stock Acquisition Rights were exercised between 8 July 2026 and 15 July 2026, and 2,334,300 shares were delivered. As a result, 98,496 unexercised Stock Acquisition Rights remained (representing 9,849,600 shares).

Worth reading
69In focus
Scored from 2 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
2334300
Shares
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Report on the large-scale exercise of the 35th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause)

発行・処分する株式数

New shares: 2,334,300 shares; treasury shares transferred: 0 shares

Intended allottee
グロース・キャピタル株式会社 (the allottee at the time of issuance)
Terms of the stock acquisition rights
Exercise price
¥49 or ¥50 (exercise price during the period). Details of the adjustment clause and floor price: Not disclosed
Number of Stock Acquisition Rights
Total issued: 147,820; exercised during the period: 23,343; unexercised balance as of the current date: 98,496
Most recent equity financing
Timing 5 June 2026 / Type Issuance of the 35th Stock Acquisition Rights (with exercise price adjustment clause) / Amount Not disclosed
Details of issuance or disposal
ItemDetails
Type of issuance or disposalReport on the large-scale exercise of the 35th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause)
Number of shares to be issued or disposed ofNew shares: 2,334,300 shares; treasury shares transferred: 0 shares
Intended allotteeグロース・キャピタル株式会社 (the allottee at the time of issuance)
Total number of issued shares60,271,100 shares (as of the end of the month preceding the subject month) → Not disclosed
Exercise price¥49 or ¥50 (exercise price during the period). Details of the adjustment clause and floor price: Not disclosed
Number of Stock Acquisition RightsTotal issued: 147,820; exercised during the period: 23,343; unexercised balance as of the current date: 98,496
Most recent equity financingTiming 5 June 2026 / Type Issuance of the 35th Stock Acquisition Rights (with exercise price adjustment clause) / Amount Not disclosed
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The company is reporting the details of the large-scale exercise that occurred.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Large-Scale Exercise of the 35th Stock Acquisition Rights (with Exercise Price Adjustment Clause) Issued Through a Third-Party Allotment | Medrx Co.,Ltd. (4586) timely disclosure | Komori